BIO-B
Bio-Rad Laboratories, Inc.

Healthcare · Medical Devices · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

4.30B USD

Market Cap

9.78B USD

Margin of Safety

-127.4%

Intrinsic / Market Ratio

0.44×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

2.66B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

3.06B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

7.18B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

4.30B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

4.30B USD

from the sum above

Market Cap

9.78B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.44×

the ratio the screener ranks by; Margin of Safety -127.4% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 2.66B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)2.42B USD
+②Net Cash Today248.35M USD
+③Growth Value0 USD
=Value2.66B USD

EPV of the Operations (NOPAT over WACC)

2.42B USD

Net cash today

+248.35M USD

Growth Value

0 USD

Value

2.66B USD

①EPV (earnings power value)

2.42B USD

②Net Cash Today

248.35M USD

③Growth Value

0 USD

Market value

Market Cap9.78B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-267.0%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 3.06B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE1.52B USD
+②Equity at Year 15, Today1.54B USD
=Value3.06B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROE on new investment rising to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

1.52B USD

②Equity at Year 15, Today

1.54B USD

Market value

Market Cap9.78B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-219.7%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 7.18B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (a change in working capital above half the operating profit in the latest three years), so the value is the book value today, 7.18B USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Cash Today

Not in the value

Market value

Market Cap9.78B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-36.2%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 9.91%
Cost of Equity =Risk-Free Rate 4.50%+Beta 1.07×Market Risk Premium 6.00%= 10.92%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 235.84M USDPretax Income 996.50M USD= 23.67%

The tax the interest saves.

Interest Expense =EBIT 1,045.54M USD−Pretax Income 996.50M USD= 49.05M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 49.05M USDTotal Debt 1.37B USD×(1 − Tax Rate for WACC 23.67%)= 2.73%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 1.37B USDMarket Cap + Total Debt 9.78B USD + 1.37B USD= 12.30%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 87.70%×Cost of Equity 10.92%+Debt Weight 12.30%×Cost of Debt 2.73%= 9.91%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 10.26B USD − Total Liabilities 3.08B USD = Book Value Today 7.18B USD

Total Debt 1.37B USD − Cash and Short-Term Investments 1.62B USD = Net Debt Today -248.35M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-6.2%at most 5%passes26,738,018 / 28,518,436
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets-2.2%at least -10.0%passes(532.73M USD − 760.66M USD) ÷ 10.26B USD
Price to bookMarket Cap ÷ Book Value Today1.36×at most 3×passes9.78B USD ÷ 7.18B USD
Operating marginOperating Income ÷ Revenue8.5%above 10.0%does not pass218.82M USD ÷ 2.59B USD
Revenue growthRevenue ÷ Revenue a Year Before − 10.7%above 10.0%does not pass2.59B USD / 2.57B USD
Net cash(Cash − Total Debt) ÷ Market Cap-8.7%above -30%passes(517.52M USD − 1.37B USD) ÷ 9.78B USD
Operating efficiencyOperating Income ÷ Gross Profit16.3%above 25.0%does not pass218.82M USD ÷ 1.34B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

365.45 USD

Enterprise value

9.52B USD

the provider's own figure

EV / EBITDA

21.57×

Price / book

1.36×

the provider's book

Price / earnings

44.47×

Return on equity

3.1%

the provider's figure, not this page's

Profit margin

8.6%

Revenue growth

-0.1%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

2.81B2.67B2.57B2.59B

Gross profit

1.57B1.43B1.38B1.34B

Operating income

475.58M338.14M269.27M218.82M

EBITDA

operating income before depreciation and amortisation

-4.53B-655.45M-2.14B1.21B

Pretax income

-4.71B-850.95M-2.34B996.50M

Net income

-3.63B-637.94M-1.85B760.66M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

383.32M294.34M239.34M203.48M

R&D

257.16M247.65M296.20M275.88M
Balance sheet, year end

Total assets

13.52B12.31B9.37B10.59B

Total liabilities

3.89B3.56B2.80B3.13B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

9.62B8.75B6.58B7.46B

Total debt

1.39B1.41B1.38B1.39B

Cash and equivalents

434.65M404.20M488.59M530.33M

Net PP&E

fixed assets after depreciation

680.23M724.42M689.29M710.61M

Working capital

current assets less current liabilities

2.59B2.53B2.57B2.39B
Cash flow

Operating cash flow

194.59M375.27M455.66M532.73M

Capital expenditure

paid out, so below zero

-114.41M-156.86M-189.19M-157.76M

Depreciation and amortisation

137.44M146.05M151.75M165.57M

Free cash flow

operating cash flow plus capital expenditure

80.18M218.42M266.47M374.97M